These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5053601)

  • 21. [Objective evaluation of immunosuppressive therapy in progressive polyarthritis using Imuran and Leukeran].
    Pavelka K; Hándlová D; Vojtísek O; Susta A; Salavcová V
    Fysiatr Revmatol Vestn; 1978 Jun; 56(3):129-37. PubMed ID: 352879
    [No Abstract]   [Full Text] [Related]  

  • 22. Recovery from severe dysphagia in systemic sclerosis - myositis overlap: a case report.
    Chinniah KJ; Mody GM
    Afr Health Sci; 2017 Jun; 17(2):593-596. PubMed ID: 29062359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of immunosuppressive drugs in the treatment of rheumatoid arthritis].
    Pascual Gómez E
    Med Clin (Barc); 1983 Oct; 81(12):540-4. PubMed ID: 6656371
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclophosphamide for scleroderma lung disease.
    Martinez FJ; McCune WJ
    N Engl J Med; 2006 Jun; 354(25):2707-9. PubMed ID: 16790705
    [No Abstract]   [Full Text] [Related]  

  • 25. [Value of immunosuppressive therapy in chronic hepatitis].
    Buligescu L
    Med Interna (Bucur); 1972 Mar; 24(3):277-84. PubMed ID: 4112750
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclophosphamide in scleroderma lung disease.
    Kuschner WG
    N Engl J Med; 2006 Sep; 355(11):1173; author reply 1174. PubMed ID: 16971726
    [No Abstract]   [Full Text] [Related]  

  • 27. [So-called immunosuppressive cytotoxic medication in acute disseminated lupus erythematosus and scleroderma].
    Thivolet J; Perrot H
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):412-4. PubMed ID: 5510738
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunosuppressive therapy in nephrotic syndrome and in chronic nephropathies in children].
    Cvorić A; Nikolić V
    Srp Arh Celok Lek; 1971; 98(9):1133-45. PubMed ID: 5130857
    [No Abstract]   [Full Text] [Related]  

  • 29. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
    Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
    [No Abstract]   [Full Text] [Related]  

  • 30. [Results of 100-day treatment of generalized scleroderma with imuran].
    Czernielewski A; Olszewska Z
    Przegl Dermatol; 1973; 60(6):761-7. PubMed ID: 4769960
    [No Abstract]   [Full Text] [Related]  

  • 31. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
    Idczak-Nowicka E; Ksiazek J; Kryński J; Wyszyńska T
    Pediatr Pol; 1996 Aug; 71(8):679-83. PubMed ID: 8927471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of endogenous uveitis. Immunosuppression].
    Martenet AC
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1980; 78():223-8. PubMed ID: 7039605
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunosuppressive therapy in clinical practice].
    Frey FJ
    Schweiz Med Wochenschr; 1987 May; 117(21):810-5. PubMed ID: 3589636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Our experience of chronic rheumatic polyarthritis therapy with immunosuppressive agents. Apropos of 41 cases].
    Arlet J; Mole J; Debrock J
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):771-4. PubMed ID: 5152709
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparison of various immunosuppressive agents in the treatment of rheumatoid polyarthritis. 41 personal cases].
    Vignon G; Bied JC
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):785-95. PubMed ID: 5152712
    [No Abstract]   [Full Text] [Related]  

  • 36. [1st data on the immunosuppressive therapy of scleroderma].
    Califano A; Cainelli T; Ghislanzoni G
    G Ital Dermatol Minerva Dermatol; 1971 Jul; 46(7):303-4. PubMed ID: 5110049
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of scleroderma].
    Mouthon L
    Rev Prat; 2002 Nov; 52(17):1915-7. PubMed ID: 12532869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of dermatologic lesions using immunosuppressive agents and cytostatics].
    Schuppli R
    Munch Med Wochenschr; 1970 Mar; 112(12):526-30. PubMed ID: 5467837
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of various immunosuppressive agents on the vascular and cellular response to carvageenan in the rat.
    Dukes M; Chan WC; Willoughby DA
    J Pathol; 1973 Feb; 109(2):151-61. PubMed ID: 4720908
    [No Abstract]   [Full Text] [Related]  

  • 40. R-74 treatment of autoimmune myositis.
    Petrányi G; Szegedi G
    Acta Med Acad Sci Hung; 1970; 27(4):351-6. PubMed ID: 5516086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.